Fidelity Management & Research led a $104m round in Kardium.

Fidelity Management & Research, an American multinational financial services corporation, led a $104m round in Kardium, a provider of medical devices, with participation from T. Rowe Price Group and Durable Capital Partners. “We are very excited to have the continued support of existing investors, and welcome Durable Capital Partners to this round. Their enthusiasm and support reflect the incredible success we have achieved with the Globe System and the tremendous potential we have to dramatically improve the treatment of atrial fibrillation for millions of patients worldwide,” Kevin Chaplin, Kardium CEO.